EI
GILD icon

Ellevest Inc’s Gilead Sciences GILD Stock Holding History

Ellevest Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$989K Buy
7,097
+1,271
+22% +$178K 0.14% 100
2025
Q4 		$715K Sell
5,826
-592
-9% -$71.9K 0.1% 148
2025
Q3 		$712K Sell
6,418
-491
-7% -$55.8K 0.1% 144
2025
Q2 		$766K Sell
6,909
-241
-3% -$25.6K 0.12% 122
2025
Q1 		$801K Sell
7,150
-2,049
-22% -$211K 0.05% 125
2024
Q4 		$850K Sell
9,199
-780
-8% -$70.2K 0.05% 122
2024
Q3 		$837K Sell
9,979
-25
-0.2% -$1.91K 0.05% 130
2024
Q2 		$686K Sell
10,004
-649
-6% -$43.3K 0.04% 152
2024
Q1 		$780K Sell
10,653
-89
-0.8% -$6.84K 0.05% 130
2023
Q4 		$870K Sell
10,742
-431
-4% -$33.5K 0.06% 96
2023
Q3 		$837K Buy
11,173
+393
+4% +$30.2K 0.06% 79
2023
Q2 		$831K Sell
10,780
-40
-0.4% -$3.19K 0.06% 76
2023
Q1 		$898K Sell
10,820
-153
-1% -$12.7K 0.07% 66
2022
Q4 		$942K Buy
10,973
+86
+0.8% +$6.81K 0.08% 61
2022
Q3 		$672K Buy
10,887
+4,814
+79% +$304K 0.06% 69
2022
Q2 		$375K Sell
6,073
-455
-7% -$28.2K 0.04% 147
2022
Q1 		$388K Buy
6,528
+930
+17% +$59.4K 0.03% 178
2021
Q4 		$406K Buy
5,598
+252
+5% +$17.4K 0.04% 149
2021
Q3 		$373K Buy
5,346
+955
+22% +$67.1K 0.04% 145
2021
Q2 		$302K Buy
4,391
+204
+5% +$13.6K 0.03% 166
2021
Q1 		$271K Buy
4,187
+1,010
+32% +$65.1K 0.03% 151
2020
Q4 		$185K Buy
3,177
+1,788
+129% +$108K 0.03% 183
2020
Q3 		$88K Sell
1,389
-192
-12% -$13.3K 0.02% 292
2020
Q2 		$122K Buy
1,581
+585
+59% +$44.8K 0.03% 166
2020
Q1 		$74K Buy
996
+310
+45% +$21.4K 0.02% 172
2019
Q4 		$45K Buy
686
+639
+1,360% +$41.6K 0.01% 212
2019
Q3 		$3K Buy
47
+12
+34% +$784 ﹤0.01% 303
2019
Q2 		$2K Sell
35
-60
-63% -$3.95K ﹤0.01% 342
2019
Q1 		$6K Buy
+95
New +$6.31K ﹤0.01% 222

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ellevest Inc's GILD Position: Q1 2026 in Review

Ellevest Inc increased its Gilead Sciences (GILD) stake by 22% in Q1 2026, buying an estimated $178K and bringing the position to 7,097 shares worth $989K. The position accounts for 0.14% of the portfolio, ranked #100.

Ellevest Inc first reported a position in GILD in Q1 2019 and has held it in 29 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Ellevest Inc held 7,097 shares of Gilead Sciences worth $989K as of Q1 2026.
  • Ellevest Inc bought 1,271 Gilead Sciences shares in Q1 2026, an estimated $178K.
  • Gilead Sciences made up 0.14% of Ellevest Inc's portfolio in Q1 2026, its #100 holding.
  • Ellevest Inc first reported a position in Gilead Sciences in Q1 2019 and has held it in 29 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Ellevest Inc's 13F filing for Q1 2026, filed 11 May 2026.